Chronic kidney disease–bone mineral disorder (CKD-MBD) includes multiple interrelated abnormalities, including hypocalcemia, hyperphosphatemia, hypovitaminosis D, and elevated levels of fibroblast growth factor 23 (FGF-23) and parathyroid hormone (PTH).1-3